3 Hidden Small-Caps Riding AI Infra and Cyber Demand in 2026

Everyone in the BullApe comments section is busy debating $DELL AI server forecasts and whether Palantir is worth 80x revenue. Meanwhile, a handful of smaller names are doing genuinely interesting things in the background, with actual catalysts on the horizon and zero coverage from the guy on CNBC in the expensive blazer.

Here are three obscure picks worth serious due diligence right now.

Credo Technology Group ($CRDO) is the one that should be embarrassing the larger cable and interconnect players. The company just reported record Q1 revenue of $479 million, up more than double year-over-year, and management raised its full-year growth outlook to over 85%. Q2 guidance landed at up to $535 million. It sits on a 68% gross margin, which is not the kind of number you expect from a company most retail investors have never heard of. The catalyst here is simple: the data center buildout everyone keeps talking about requires active electrical cables and high-speed connectivity at scale, and Credo makes the silicon that powers exactly that. Optical revenue is tracking past $600 million this year, with the company projecting massive expansion through fiscal 2028. The bear case is valuation, because nothing growing at 85% stays cheap for long, and any guidance miss would be brutal. But the Seeking Alpha quant model currently flags it as a strong buy, and it is hard to argue with that momentum.

Sievert Larsen and the sleep-health adjacency play: Inspire Medical Systems ($INSP) is a mid-cap medical device company that makes an implantable neurostimulator to treat obstructive sleep apnea. With GLP-1 drugs changing the body-weight conversation and awareness of sleep disorders exploding, Inspire sits at the intersection of two of the hottest health themes in the market. The company has been posting consistent double-digit revenue growth, and its total addressable market remains massively underpenetrated given that roughly 80% of sleep apnea cases go undiagnosed. The near-term catalyst is continued physician adoption and potential expansion into new international markets. The bear case is reimbursement risk and competition from CPAP improvements, but the clinical outcomes data remains strong.

Coda Octopus Group ($CODA) is perhaps the most genuinely obscure name on this list. The company makes underwater mapping technology and real-time 3D sonar systems used by navies, offshore energy operators, and port authorities. With geopolitical tensions in the Persian Gulf showing up across every Bloomberg headline right now, and the US Navy modernizing its underwater domain awareness, CODA is a niche defense and ocean-tech play with a market cap small enough that a single contract announcement could move it meaningfully. Revenue is growing in the low double digits, margins are expanding, and the company is profitable, which puts it in rare company among small defense tech names.

The common thread across all three: real revenue, specific catalysts, and the kind of boring-but-defensible business model that tends to survive whatever geopolitical chaos September decides to throw at us next.